ATRX is frequently lost in cancer cells utilizing the ALT (alternative lengthening of telomeres) pathway to maintain telomeres (Heaphy et al, 2011; Li et al, 2019), and persistent sister-telomere cohesion has been linked to ATRX loss (Ramamoorthy and Smith, 2015). Here, ATRX is linked to cancer.